Acceptance and commitment therapy for destructive experiential avoidance (ACT-DEA): a pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005491

Enrollment

Registered

2020-10-15

Start date

2019-09-10

Completion date

Unknown

Last updated

2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : The Acceptance and commitment therapy (ACT) intervention will consist of 6 weekly individual sessions of 40-minutes each and pharmacological treatment. The treatment as usual (TAU) will c

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adolescents (aged 15-25 years) who had destructive experiential avoidant behaviors within the previous 3 months

Exclusion criteria

Exclusion criteria: 1. Current moderate to high suicide risk 2. Severely acute phase of mental illness 3. History of brain injury and/or organic mental disease 4. Suspected of intellectual disability

Design outcomes

Primary

Measure	Time frame
Frequency of Destructive Experiential Avoidance;Brief form of Multidimensional Experiential Avoidance Questionnaire (K-MEAQ-24)	—

Secondary

Measure	Time frame
Patient Health Questionnaire-9 (PHQ-9);General Anxiety Disorder-7 (GAD-7);WHO Quality of Life-BREF (WHOQOL-BREF)	—

Countries

Korea, Republic of

Contacts

Public ContactEuihyeon

Presbyterian Medical Center

Outcome results